Patents
Patents for C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294)
07/2011
07/20/2011CN102127124A Method for preparing hydroxysafflor yellow A
07/20/2011CN101531687B Derivatizing reagent of polyhydroxy compound
07/14/2011US20110171159 Glycoside Derivatives and Uses Thereof
07/12/2011US7977466 C-glycoside derivatives and salts thereof
07/12/2011CA2497167C Modified saccharides, conjugates thereof, and their manufacture
07/07/2011WO2011079772A1 Method for preparation of 2,5-disubstituted thiophene compound
07/07/2011WO2010067008A3 Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
07/05/2011US7973013 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
06/2011
06/30/2011WO2010067010A3 Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/30/2011WO2010063953A3 Novel amino c-xyloside compounds, and cosmetic use
06/30/2011DE102006053637B4 Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New fluoro-substituted 1,4-benzothiepine-1,1-dioxide derivatives, pharmaceutical compositions containing them and their use
06/23/2011WO2011048554A3 Combination of a probiotic lysate and a c-glycoside derivative
06/16/2011US20110144321 Synthetic intermediates and processes
06/16/2011US20110144281 Amphiphilic polymers having a cholane core
06/07/2011CA2455774C Sugar derivatives of hydromorphone, dihydromorphine and dihydroisomorphine, compositions thereof and uses for treating or preventing pain
06/02/2011US20110130440 Non-natural ribonucleotides, and methods of use thereof
05/2011
05/31/2011CA2634299C Process for preparing inhibitors of nucleoside metabolism
05/26/2011US20110124573 Osmoprotective Complexes for Prevention of Intra-cellular Dehydration in Mammals
05/25/2011CN101475612B Method for synthesizing D-mannoheptulose
05/18/2011EP2322533A1 Process for producing sugar chain asparagine derivative
05/18/2011EP2322532A1 Method for releasing reducing glycan by ammonium salt
05/17/2011US7943582 Canagliflozin, a sodium-glucose transporter 2 inhibitor as antiobesity, antidiabetic agent; purity; handling characteristics; easy formulation; storage stability
05/12/2011WO2011057192A2 Amphiphilic compositions and methods for preparing and using same
05/12/2011US20110112282 Ido inhibitors and therapeutic uses thereof
05/12/2011US20110112042 Novel flavonol compounds, a bioactive extract/fraction from ulmus wallichiana and its compounds for prevention for treatment of osteo-health related disorders
05/12/2011CA2780151A1 Amphiphilic comp0unds and methods for preparing and using same
05/11/2011EP2319853A1 Process for the production of 2'-branched nucleosides
05/11/2011CN101434624B Method and apparatus for refining D-glucuronolactone
05/05/2011WO2011051864A1 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
05/05/2011CA2777857A1 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
05/04/2011CN102046645A Crystal of spiroketal derivative, and process for production thereof
04/2011
04/28/2011WO2011048554A2 Combination of a probiotic lysate and a c-glycoside derivative
04/27/2011EP2312944A1 Deuterated benzylbenzene derivatives and methods of use
04/26/2011US7932379 Methods of producing C-aryl glucoside SGLT2 inhibitors
04/21/2011WO2011046057A1 Novel sugar chain compound containing sialyllactosamine-type or sialyl lewis x-type sialic acid and fucose
04/14/2011WO2011043107A1 Method for extraction of compound containing sialic acid from plant
04/14/2011US20110087017 Process for the preparation of compounds useful as inhibitors of sglt2
04/13/2011EP2308886A1 Crystal of spiroketal derivative, and process for production thereof
04/13/2011EP2308841A2 Phlorizin analogs as SGLT2 inhibitors
04/07/2011WO2011040360A1 Method for separating sialyllactose material
04/07/2011US20110082289 Nucleic Acid Labeling Compounds
04/06/2011CN102002077A Novel conjugate of sialic acid-zinc methionine, preparation process and application thereof
04/06/2011CA2718448A1 Extraction method for sialic acid-containing compound from plant
04/05/2011US7919598 Crystal structures of SGLT2 inhibitors and processes for preparing same
03/2011
03/30/2011CN101998962A Novel aromatic fluoroglycoside derivatives, pharmaceuticals comprising said compounds, and the use thereof
03/24/2011US20110071285 Low-molecular serine proteases inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
03/24/2011US20110070194 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
03/10/2011US20110059910 Novel aromatic fluoroglycoside derivatives, pharmaceuticals comprising said compounds and the use thereof
03/10/2011US20110059907 Chiral Complexes of Ascorbic Acid with Natural Antioxidant and Anti-Inflammatory Ketones Including Aloe, Citrus, Ginger, and Mango for Skin and Hair Care
02/2011
02/24/2011US20110046078 Methods and compositions for treating diseases and disorders associated with siglec-8
02/16/2011CN101974038A Oligomeric amino sugar acid and preparation method thereof
02/15/2011US7888500 Preparation and uses of locked-ring sugar C-glycoside derivatives
02/15/2011US7887833 Amphiphilic compounds and vesicles liposomes for organ-specified drug targeting
02/10/2011US20110034402 C-aryl glycoside compounds for the treatment of diabetes and obesity
02/09/2011EP2280985A2 Use of mannose-6-phosphate for controlling angiogenesis, ligament regeneration, and cartilage reconstruction
02/09/2011EP2280983A2 C-aryl glycoside compounds for the treatment of diabetes and obesity
02/03/2011WO2011013398A1 Compound having high affinity for cd22 molecule and capable of enhancing proliferation of b cells
02/03/2011US20110028414 Glucopyranoside derivatives
02/02/2011EP2280018A1 Method for extracting sialic acid-containing compound from plant
02/01/2011US7879809 Controlling ectoparasite infestations in aquaculture; adding spinosyn component to feed
01/2011
01/26/2011EP2276773A2 Compounds with glycidic structure active in the therapy of systemic and local inflammation
01/19/2011CN101952237A Bromide-free TEMPO-mediated oxidation of the primary alcohol in carbohydrate under two-phase conditions
01/11/2011CA2429781C Linkable sialyl lewis x analogs
01/06/2011WO2010113035A3 Peptide-based beta turn mimetics
01/05/2011EP2268653A2 Novel aromatic fluoroglycoside derivatives, pharmaceuticals comprising said compounds, and the use thereof
01/05/2011CN101935680A Pectin oligogalacturonic acid copper and preparation method and application thereof
12/2010
12/29/2010EP2099812B1 Manufacturing method of tagatose using galactose isomerization of high yield
12/28/2010US7858775 Production of 2′-deoxynucleosides and 2′-deoxynucleoside precursors from 2-dehydro-3-deoxy-D-gluconate
12/22/2010EP2262821A2 Process for the extraction of mangiferin and isomangiferin
12/21/2010CA2351836C Glycosphingolipid
12/16/2010US20100317847 Crystalline form of 4-(beta-d-glucopyranos-1-yl)-1-methyl-2-[4-((s)-tetrahydrofuran-3-yloxy)-benzyl]-benzene, a method for its preparation and the use thereof for preparing medicaments
12/16/2010US20100317842 Development of Molecular Imaging Probes for Carbonic Anhydrase-IX Using Click Chemistry
12/15/2010EP2260051A1 Glucopyranoside derivatives
12/15/2010EP1926720B1 CRYSTALLINE FORMS OF 1-CHLORO-4-(ß-D-GLUCOPYRANOS-1-YL)-2-(4-ETHYNYL-BENZYL)-BENZENE, METHODS FOR ITS PREPARATION AND THE USE THEREOF FOR PREPARING MEDICAMENTS
12/15/2010CN101918423A Organic compounds
12/14/2010US7851602 Glucopyranosyl-substituted ((hetero)cycloalkylethynyl-benzyl)-benzene derivatives, medicaments containing such compounds, their use and process for their manufacture
12/09/2010US20100311684 Novel tricyclic nucleosides or nucleotides as therapeutic agents
12/01/2010EP2256103A1 Novel indicator platform
11/2010
11/25/2010US20100297078 Method for producing a hydroxyalkyl starch derivative with two linkers
11/18/2010WO2010131745A1 18f-labeled azide compound, reagent for 18f-labeling and method for 18f-labeling of alkyne compound using same
11/18/2010WO2010131712A1 Therapeutic pharmaceutical agent for diseases associated with decrease in function of gne protein, food composition, and food additive
11/11/2010WO2010128152A1 Fused heterocyclic c-glycosides for the treatment of diabetes
11/11/2010WO2010128120A1 Novel indicator platform
11/11/2010WO2009121939A3 C-aryl glycoside compounds for the treatment of diabetes and obesity
11/10/2010CN101880299A Purification method of Bajisin
11/09/2010CA2315953C 3'-epimeric k-252a derivatives
11/03/2010EP1242437B1 Novel stromelysin inhibitors
10/2010
10/26/2010US7820783 Contain chemically reactive carbocyanine dyes that are intramolecularly crosslinked between the 1-position and 3'-position, their bioconjugates
10/26/2010US7820714 Increased selectivity for sialic acid binding Ig-like lectins (Siglec); improving immune response dependent on B-cells
10/20/2010CN101863929A Method for detecting bacterial vaginosis
10/19/2010US7816328 such as 3-(4-Ethylbenzyl)-5-( beta -D-glucopyranosyl)-1H-indole, used for for treating diabetes, Syndrome X, or associated symptoms selected from obesity, nephropathy, neuropathy, retinopathy, atherosclerosis, polycystic ovarian syndrome, hypertension, ischemia, stroke and cardiovascula disorders
10/14/2010WO2010059958A3 Artificial lectin mimics and uses thereof
10/07/2010US20100256333 Peptide-Based Beta Turn Mimetics
10/06/2010EP2236137A1 Pharmaceutical composition for treatment of fatty liver diseases
09/2010
09/30/2010US20100249392 Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
09/30/2010US20100249057 Trehalose compound and pharmaceutical comprising the compound
09/30/2010US20100249046 Novel mangiferin calcium salts, the method for its preparation and its use
09/29/2010CN101125837B C-glycosides type slycolipid compounds and use thereof
09/28/2010US7803600 inhibitors of vacuolar-type H+-ATPase; antibiotic; (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16- [(1S,2R,3S)-3-[(2R,4R,5S,6R)-2,4-dihydroxy-6- isopropyl-5-methyl-2-tetrahydropyranyl]-2- hydroxy-1-methylbutyl]-8-hydroxy-3,15- dimethoxy-5,7,9,11-tetramethyl-1- oxacyclohexadeca-3,5,11,13-tetraen-2-one
09/16/2010WO2010102512A1 C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 23